What is the treatment guideline for a 14-year-old patient who has taken an overdose of 24 Dolo (paracetamol) tablets, is stable, but complains of stomach ache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate IV NAC Administration is Indicated

For this 14-year-old patient who ingested 24 Dolo (paracetamol) tablets, you must initiate intravenous N-acetylcysteine (NAC) immediately, regardless of timing or acetaminophen levels, given the potentially hepatotoxic dose and presence of symptoms. 1, 2, 3

Dose Assessment and Risk Stratification

  • 24 tablets of standard Dolo (500mg each) = 12 grams total, which exceeds the hepatotoxic threshold of 10g/day and represents a dose >150 mg/kg for most 14-year-olds 2, 4
  • This ingestion places the patient at high risk for severe hepatotoxicity, with mortality risk directly correlating to treatment delay 1, 2
  • The stomach ache may represent early gastrointestinal symptoms or evolving hepatotoxicity 2

Immediate Management Algorithm

Step 1: Start IV NAC Without Delay

Do not wait for acetaminophen levels or laboratory results before initiating NAC 1, 2, 3

  • If timing of ingestion is unknown or >8 hours has passed: administer loading dose immediately 3
  • If acetaminophen concentration cannot be obtained within 8 hours: administer loading dose immediately and continue full 21-hour protocol 3
  • The critical window is 0-8 hours post-ingestion where NAC provides maximal hepatoprotection (only 2.9% develop severe hepatotoxicity when treated within 8 hours vs 26.4% when started 10-24 hours later) 1, 2

Step 2: IV NAC Dosing Protocol (21-Hour Regimen)

Standard three-bag IV protocol 1, 2, 3:

  • Loading dose: 150 mg/kg IV over 15 minutes 1, 3
  • Second dose: 50 mg/kg IV over 4 hours 1, 3
  • Third dose: 100 mg/kg IV over 16 hours (total 21-hour protocol) 1, 3
  • Total dose: 300 mg/kg over 21 hours 3

Step 3: Urgent Laboratory Assessment

Obtain immediately (do not delay NAC for these results) 2, 3:

  • Acetaminophen level (if ≥4 hours post-ingestion; levels drawn <4 hours are unreliable) 2, 3
  • AST, ALT (baseline and repeat every 12-24 hours for first 72 hours) 2, 4, 3
  • INR/PT (coagulopathy is red flag for liver failure) 2, 4
  • Bilirubin, creatinine, BUN 3
  • Blood glucose, electrolytes 3

Step 4: Consider Activated Charcoal (Time-Dependent)

  • If patient presents within 4 hours of ingestion, give activated charcoal 1g/kg orally just prior to starting NAC 1, 2
  • Do not delay NAC administration even if activated charcoal is given 1
  • Charcoal is ineffective if >4 hours have passed since ingestion 2

Critical Red Flags Requiring Extended NAC Beyond 21 Hours

Continue or restart NAC immediately if any of the following develop 1, 2:

  • Any elevation in AST or ALT above normal 1, 2
  • Rising transaminases (even if initially normal) 1, 2
  • Any coagulopathy (INR >1.5) 2, 4
  • Detectable acetaminophen level at end of 21-hour protocol 1, 2
  • AST/ALT >1000 IU/L (severe hepatotoxicity—continue NAC until transaminases declining and INR normalizes) 1, 2

Special Considerations for This Case

Why IV Route is Preferred Over Oral

  • IV NAC is superior for established or evolving hepatotoxicity 1
  • The 21-hour IV protocol may be too short for some patients; monitor closely and extend if red flags develop 1, 5
  • Oral NAC (72-hour protocol) is equally effective but less practical in acute presentations with potential vomiting 1, 5

Rumack-Matthew Nomogram Limitations

  • The nomogram does NOT apply if timing is uncertain or if this represents repeated supratherapeutic ingestion over >24 hours 2, 4, 3
  • For single acute ingestion with known timing: plot acetaminophen level drawn 4-24 hours post-ingestion on nomogram 2, 3
  • If level plots above "possible toxicity" line: continue full 21-hour NAC protocol 2, 3
  • However, given the 12g dose, treat regardless of nomogram placement 2

Critical Pitfalls to Avoid

  1. Do not delay NAC while awaiting acetaminophen levels—efficacy is time-dependent, and low/absent levels do not rule out toxicity if ingestion was remote 1, 2

  2. Do not stop NAC prematurely at 21 hours if any red flags are present (elevated transaminases, detectable acetaminophen, coagulopathy) 1, 2

  3. Do not rely solely on patient stability—hepatotoxicity may not manifest clinically for 24-72 hours, but hepatocellular injury begins within hours 2, 6

  4. Do not assume stomach ache is benign—monitor closely for evolving hepatotoxicity with serial liver function tests 2, 4

Monitoring and Disposition

  • Admit for observation with serial AST/ALT/INR every 12-24 hours for minimum 72 hours 2, 4
  • ICU-level care required if: AST/ALT >1000 IU/L, any coagulopathy, altered mental status, or signs of acute liver failure 1, 2
  • Contact transplant center immediately if severe hepatotoxicity develops (AST/ALT >3500 IU/L, INR >1.5, encephalopathy) 2, 4

Evidence for Late NAC Administration

Even if >24 hours have passed since ingestion, NAC still provides significant benefit and reduces mortality from 80% to 52% in fulminant hepatic failure 1, 2, 7, 8. Late NAC administration (even 72+ hours post-ingestion) has successfully reversed hepatic failure in case reports 7, 8.

References

Guideline

N-Acetylcysteine Administration in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Acetaminophen Overdose in Patients with Dengue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacokinetics of paracetamol.

Clinical pharmacokinetics, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.